Opthea Limited (NASDAQ: OPT), an Australian biotechnology firm, is at the forefront of developing cutting-edge therapies for ocular conditions. With its core research concentrated on vascular..
Standard BioTools Inc. (NASDAQ: LAB), a dynamic player in the medical devices industry, has piqued investor interest with a potential upside of 37.6%, according to recent..
Autolus Therapeutics plc (NASDAQ: AUTL), a pioneering player in the biotechnology sector, is capturing investor attention with its innovative T cell therapies aimed at treating cancer..
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company nestled in the healthcare sector, is gaining traction among investors intrigued by its promising potential upside. With a..
Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector, specifically within the medical devices industry, presents a fascinating case for investors as it navigates..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to combating cancer resistance mechanisms. With..
AbCellera Biologics Inc. (NASDAQ: ABCL), a cutting-edge player in the biotechnology sector, is a company that has caught the attention of investors with its promising 59.82%..
For investors seeking a potentially rewarding opportunity in the healthcare sector, Semler Scientific, Inc. (NASDAQ: SMLR) presents an intriguing case. This medical device company, headquartered in..
For investors eyeing the healthcare sector, particularly within the niche of animal health and nutrition, Phibro Animal Health Corporation (NASDAQ: PAHC) presents an intriguing case. With..
MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing significant attention from the investment community due to its promising outlook in the biotechnology industry. With a market capitalization..
CorMedix Inc. (NASDAQ: CRMD), a pioneering entity in the biotechnology sector, has garnered significant investor attention with its ambitious pipeline aimed at addressing life-threatening diseases. As..
Theravance Biopharma, Inc. (NASDAQ: TBPH) is capturing investor attention with its considerable potential upside of 42.45%, according to analysts’ average target prices. As a biopharmaceutical company,..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) has emerged as a compelling player in the biotechnology sector, focusing on pioneering gene therapies for rare and life-threatening diseases. With..
COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology company focusing on mental health treatment, is capturing the attention of investors with its remarkable potential upside of..
OrthoPediatrics Corp. (NASDAQ: KIDS), a niche player in the healthcare sector specializing in pediatric orthopedic medical devices, is drawing considerable attention from investors. Despite recent challenges,..
PureTech Health plc (NASDAQ: PRTC), a biotechnology company with an intriguing mix of advanced therapeutic candidates, is capturing the attention of investors with its significant potential..
SI-BONE, Inc. (NASDAQ: SIBN), a leading player in the medical devices sector, has emerged as an intriguing investment opportunity for those seeking high growth potential in..
In the dynamic and often unpredictable world of biotechnology, Cel-Sci Corporation (NASDAQ: CVM) presents an intriguing proposition for investors seeking high-risk, high-reward opportunities. With a staggering..
InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, particularly in the medical care facilities industry, offers a unique business model that focuses..
